Search Results 311-320 of 23847 for prostate cancer
The purpose of this study is to test how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and who have ...
A Study of Carboplatin, Cabazitaxel and Abiraterone in High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA). Print details. Share; Facebook ...
In men, radical cystectomy typically includes removal of the prostate and seminal vesicles. In women, radical cystectomy may involve removal of the uterus ...
XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer · More about research ...
... prostate gland, which is also known as benign prostatic ... prostate cancer but may increase your risk of developing high-grade prostate cancer.
Could a little red wine lower your risk of prostate cancer? In this Mayo Clinic Radio Health Minute, Dr. Jeffrey Karnes says maybe. To listen, click the ...
... prostate gland, which is also known as benign prostatic hyperplasia (BPH). ... prostate cancer. Make sure you tell all of your doctors that you are using ...
... prostate cancer. Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the ...
Jason. Exercise is good for the body, and that holds true for men with prostate cancer. 06:11. Mitchell Humphreys, M.D.. Urology. Mayo Clinic. "What we found is ...
Phase III Study of DCVAC Added to Standard Chemotherapy for Men with Metastatic Castration Resistant Prostate Cancer · More about research at Mayo Clinic · Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.